636 is the total number of securities Eventide Asset Management has owned. The longest Eventide Asset Management has owned a single stock is 40 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
LOW | LOWES COS INC | 40 | 40 | 1.30% | 2.12% | 3.22% | Q4 2013 | Q3 2023 | 40 |
PANW | PALO ALTO NETWORKS INC | 40 | 40 | 0.48% | 1.78% | 3.63% | Q4 2013 | Q3 2023 | 40 |
ASML | ASML HOLDINGS NV | 40 | 40 | 0.56% | 1.36% | 1.90% | Q4 2013 | Q3 2023 | 40 |
NBIX | NEUROCRINE BIOSCIENCES... | 40 | 40 | 0.11% | 0.48% | 1.07% | Q4 2013 | Q3 2023 | 40 |
RGEN | REPLIGEN CORP | 40 | 40 | 0.11% | 0.29% | 0.45% | Q4 2013 | Q3 2023 | 40 |
VCYT | VERACYTE INC | 38 | 38 | 0.18% | 0.68% | 1.46% | Q2 2014 | Q3 2023 | 38 |
LRCX | LAM RESEARCH CORP | 35 | 35 | 0.82% | 1.81% | 3.44% | Q1 2015 | Q3 2023 | 35 |
XPO | XPO LOGISTICS INC | 34 | 34 | 0.00% | 1.58% | 3.76% | Q4 2014 | Q1 2023 | 34 |
COLL | COLLEGIUM PHARMACEUTIC... | 34 | 34 | 0.63% | 1.29% | 2.64% | Q2 2015 | Q3 2023 | 34 |
MGA | MAGNA INTL INC | 33 | 33 | 0.71% | 1.50% | 2.49% | Q4 2013 | Q4 2021 | 33 |
NEP | NEXTERA ENERGY PARTNER... | 33 | 33 | 0.00% | 1.46% | 2.17% | Q3 2015 | Q3 2023 | 33 |
CCI | CROWN CASTLE INTL CORP... | 33 | 33 | 0.58% | 1.44% | 3.26% | Q1 2015 | Q1 2023 | 33 |
BPMC | BLUEPRINT MEDICINES CORP | 33 | 33 | 0.13% | 0.65% | 1.32% | Q3 2015 | Q3 2023 | 33 |
BEP | BROOKFIELD RENEWABLE P... | 33 | 33 | 0.00% | 0.43% | 1.26% | Q3 2015 | Q3 2023 | 33 |
HASI | HANNON ARMSTRONG SUST ... | 32 | 32 | 0.08% | 0.65% | 1.00% | Q4 2015 | Q3 2023 | 32 |
TSM | TAIWAN SEMICONDUCTOR M... | 17 | 13 | 0.00% | 0.20% | 0.79% | Q3 2015 | Q3 2023 | 30 |
XNCR | XENCOR INC | 29 | 29 | 0.21% | 0.33% | 0.59% | Q1 2015 | Q1 2022 | 29 |
ASND | ASCENDIS PHARMA A/S | 28 | 28 | 0.30% | 3.40% | 6.88% | Q4 2016 | Q3 2023 | 28 |
WCN | WASTE CONNECTIONS INC | 28 | 28 | 0.90% | 1.73% | 2.44% | Q4 2016 | Q3 2023 | 28 |
SRPT | SAREPTA THERAPEUTICS INC | 15 | 3 | 0.24% | 1.66% | 5.19% | Q4 2013 | Q3 2023 | 28 |
IPHI | INPHI CORP | 28 | 28 | 0.75% | 1.22% | 2.32% | Q4 2013 | Q3 2020 | 28 |
GWPH | GW PHARMACEUTICALS PLC | 27 | 27 | 0.18% | 0.51% | 1.28% | Q2 2014 | Q4 2020 | 27 |
TTD | THE TRADE DESK INC | 26 | 26 | 0.84% | 2.19% | 3.34% | Q2 2017 | Q3 2023 | 26 |
EXAS | EXACT SCIENCES CORP | 26 | 26 | 0.22% | 1.65% | 3.54% | Q2 2017 | Q3 2023 | 26 |
HUBS | HUBSPOT INC | 26 | 26 | 0.85% | 1.52% | 2.12% | Q2 2017 | Q3 2023 | 26 |
STML | STEMLINE THERAPEUTICS INC | 26 | 26 | 0.22% | 0.77% | 1.49% | Q4 2013 | Q1 2020 | 26 |
FIVN | FIVE9 INC | 25 | 25 | 0.75% | 1.96% | 3.13% | Q3 2017 | Q3 2023 | 25 |
LEA | LEAR CORP | 25 | 25 | 0.71% | 1.87% | 3.25% | Q4 2013 | Q4 2019 | 25 |
XLRN | ACCELERON PHARMA INC | 20 | 5 | 0.13% | 0.58% | 1.45% | Q2 2014 | Q1 2021 | 25 |
SPLK | SPLUNK INC | 24 | 24 | 0.67% | 1.75% | 2.62% | Q4 2014 | Q3 2020 | 24 |
KAR | KAR AUCTION SVCS INC | 24 | 24 | 0.46% | 1.62% | 2.60% | Q4 2013 | Q3 2019 | 24 |
STKL | SUNOPTA INC | 24 | 24 | 0.25% | 1.26% | 2.47% | Q4 2013 | Q3 2019 | 24 |
APTV | APTIV PLC | 24 | 24 | 0.70% | 1.03% | 1.48% | Q4 2017 | Q3 2023 | 24 |
BMRN | BIOMARIN PHARMACEUTICA... | 20 | 4 | 0.22% | 0.35% | 0.49% | Q4 2013 | Q3 2023 | 24 |
MIC | MACQUARIE INFRASTRUCTU... | 23 | 23 | 0.36% | 2.43% | 3.85% | Q4 2013 | Q2 2019 | 23 |
BLUE | BLUEBIRD BIO INC | 23 | 23 | 0.14% | 2.02% | 3.90% | Q4 2013 | Q2 2019 | 23 |
ROP | ROPER TECHNOLOGIES INC | 23 | 23 | 0.78% | 1.91% | 2.52% | Q1 2018 | Q3 2023 | 23 |
ARGX | ARGENX SE | 23 | 23 | 0.34% | 1.41% | 2.84% | Q1 2018 | Q3 2023 | 23 |
SAGE | SAGE THERAPEUTICS INC | 23 | 23 | 0.15% | 1.36% | 4.41% | Q3 2014 | Q1 2020 | 23 |
RARE | ULTRAGENYX PHARMACEUTI... | 18 | 5 | 0.21% | 0.33% | 0.59% | Q2 2014 | Q3 2023 | 23 |
MTD | METTLER TOLEDO INTERNA... | 22 | 22 | 0.65% | 2.03% | 3.70% | Q2 2018 | Q3 2023 | 22 |
WBC | WABCO HLDGS INC | 22 | 22 | 0.61% | 1.71% | 2.36% | Q4 2013 | Q1 2019 | 22 |
MGNX | MACROGENICS INC | 20 | 2 | 0.12% | 0.56% | 1.32% | Q4 2013 | Q2 2019 | 22 |
KALV | KALVISTA PHARMACEUTICA... | 20 | 2 | 0.02% | 0.41% | 1.01% | Q1 2017 | Q4 2022 | 22 |
PLD | PROLOGIS INC. | 22 | 22 | 0.02% | 0.17% | 0.50% | Q2 2018 | Q3 2023 | 22 |
W | WAYFAIR INC | 21 | 21 | 0.80% | 1.93% | 3.28% | Q4 2016 | Q4 2021 | 21 |
BHVN | BIOHAVEN PHARMACTL HLD... | 21 | 21 | 0.08% | 1.68% | 3.52% | Q2 2017 | Q2 2022 | 21 |
ABBV | ABBVIE INC | 20 | 20 | 0.01% | 2.39% | 3.42% | Q4 2013 | Q3 2018 | 20 |
AGIO | AGIOS PHARMACEUTICALS INC | 20 | 20 | 0.21% | 1.34% | 3.70% | Q4 2013 | Q3 2018 | 20 |
PFPT | PROOFPOINT INC | 20 | 20 | 0.51% | 1.14% | 1.90% | Q1 2015 | Q4 2019 | 20 |
EXR | EXTRA SPACE STORAGE INC | 20 | 20 | 0.26% | 0.73% | 2.42% | Q1 2015 | Q4 2019 | 20 |
GLPG | GALAPAGOS NV | 20 | 20 | 0.12% | 0.29% | 0.87% | Q1 2016 | Q4 2020 | 20 |
ACAD | ACADIA PHARMACEUTICALS... | 19 | 19 | 0.07% | 0.74% | 1.47% | Q4 2013 | Q2 2018 | 19 |
SUPN | SUPERNUS PHARMACEUTICA... | 19 | 19 | 0.23% | 0.40% | 0.77% | Q1 2014 | Q3 2018 | 19 |
CERN | CERNER CORP | 19 | 19 | 0.24% | 0.34% | 0.45% | Q1 2014 | Q3 2018 | 19 |
ARE | ALEXANDRIA REAL ESTATE... | 19 | 19 | 0.04% | 0.08% | 0.12% | Q2 2018 | Q4 2022 | 19 |
CELG | CELGENE CORP | 18 | 18 | 0.39% | 2.59% | 4.26% | Q2 2014 | Q3 2018 | 18 |
IDXX | IDEXX LABS INC | 18 | 18 | 0.76% | 1.72% | 2.42% | Q2 2019 | Q3 2023 | 18 |
ODFL | OLD DOMINION FREIGHT L... | 17 | 1 | 0.06% | 1.70% | 3.26% | Q3 2016 | Q3 2023 | 18 |
STLD | STEEL DYNAMICS INC | 18 | 18 | 0.69% | 1.61% | 2.24% | Q1 2015 | Q2 2019 | 18 |
KRTX | KARUNA THERAPEUTICS INC | 18 | 18 | 0.16% | 1.36% | 2.30% | Q2 2019 | Q3 2023 | 18 |
TSLA | TESLA MTRS INC | 18 | 18 | 0.37% | 0.88% | 1.60% | Q4 2013 | Q1 2018 | 18 |
AY | ATLANTICA YIELD PLC | 18 | 18 | 0.41% | 0.80% | 1.28% | Q2 2016 | Q3 2020 | 18 |
ATHN | ATHENAHEALTH INC | 18 | 18 | 0.10% | 0.59% | 1.70% | Q4 2013 | Q1 2018 | 18 |
MRTX | MIRATI THERAPEUTICS INC | 18 | 18 | 0.16% | 0.52% | 1.09% | Q2 2019 | Q3 2023 | 18 |
GBT | GLOBAL BLOOD THERAPEUT... | 9 | 9 | 0.04% | 0.49% | 1.20% | Q3 2015 | Q3 2020 | 18 |
QURE | UNIQURE NV | 10 | 8 | 0.04% | 0.49% | 1.18% | Q2 2014 | Q2 2020 | 18 |
ISRG | INTUITIVE SURGICAL INC | 18 | 18 | 0.27% | 0.36% | 0.45% | Q2 2019 | Q3 2023 | 18 |
XENE | XENON PHARMACEUTICALS INC | 12 | 6 | 0.12% | 0.33% | 0.50% | Q3 2018 | Q3 2023 | 18 |
EPIX | ESSA PHARMA INC | 18 | 18 | 0.04% | 0.31% | 1.04% | Q2 2018 | Q3 2022 | 18 |
TWLO | TWILIO INC | 12 | 5 | 0.58% | 1.84% | 3.68% | Q1 2017 | Q3 2021 | 17 |
FPRX | FIVE PRIME THERAPEUTIC... | 17 | 17 | 0.08% | 1.70% | 3.25% | Q1 2014 | Q1 2018 | 17 |
POOL | POOL CORPORATION | 17 | 17 | 1.11% | 1.53% | 1.86% | Q3 2019 | Q3 2023 | 17 |
SGEN | SEATTLE GENETICS INC | 14 | 3 | 0.34% | 1.28% | 2.76% | Q2 2015 | Q3 2020 | 17 |
PEGI | PATTERN ENERGY GROUP INC | 17 | 17 | 0.00% | 0.91% | 1.32% | Q3 2015 | Q3 2019 | 17 |
DDOG | DATADOG INC | 17 | 17 | 0.32% | 0.75% | 1.20% | Q3 2019 | Q3 2023 | 17 |
STRO | SUTRO BIOPHARMA INC | 17 | 17 | 0.16% | 0.47% | 0.80% | Q3 2018 | Q3 2022 | 17 |
PRTA | PROTHENA CORP PLC | 11 | 1 | 0.06% | 0.35% | 0.52% | Q1 2014 | Q3 2023 | 17 |
NTUS | NATUS MEDICAL INC DEL | 17 | 17 | 0.15% | 0.22% | 0.36% | Q4 2013 | Q4 2017 | 17 |
IEX | IDEX CORP | 17 | 17 | 0.02% | 0.14% | 0.31% | Q3 2019 | Q3 2023 | 17 |
ABB | ABB LTD | 17 | 17 | 0.00% | 0.06% | 0.11% | Q3 2015 | Q3 2019 | 17 |
ETN | EATON CORP PLC | 17 | 17 | 0.00% | 0.04% | 0.08% | Q3 2015 | Q3 2019 | 17 |
ERIC | ERICSSON | 17 | 17 | 0.01% | 0.03% | 0.08% | Q3 2015 | Q3 2019 | 17 |
LOXO | LOXO ONCOLOGY INC | 16 | 16 | 0.11% | 1.21% | 2.65% | Q1 2015 | Q4 2018 | 16 |
DHI | D R HORTON INC | 16 | 16 | 0.03% | 1.09% | 1.48% | Q4 2019 | Q3 2023 | 16 |
TREX | TREX CO INC | 16 | 16 | 0.74% | 1.05% | 1.71% | Q4 2019 | Q3 2023 | 16 |
LII | LENNOX INTL INC | 16 | 16 | 0.37% | 0.98% | 1.61% | Q4 2017 | Q3 2021 | 16 |
VRTX | VERTEX PHARMACEUTICALS... | 14 | 2 | 0.15% | 0.79% | 2.22% | Q4 2015 | Q2 2020 | 16 |
NOVT | NOVANTA INC | 16 | 16 | 0.29% | 0.53% | 0.73% | Q4 2019 | Q3 2023 | 16 |
TTPH | TETRAPHASE PHARMACEUTI... | 9 | 7 | 0.07% | 0.42% | 1.26% | Q4 2013 | Q4 2017 | 16 |
ATRC | ATRICURE INC | 16 | 16 | 0.16% | 0.26% | 0.42% | Q4 2013 | Q3 2017 | 16 |
KLAC | KLA CORPORATION | 16 | 16 | 0.03% | 0.26% | 0.55% | Q4 2019 | Q3 2023 | 16 |
LPT | LIBERTY PPTY TR | 16 | 16 | 0.00% | 0.02% | 0.03% | Q3 2015 | Q2 2019 | 16 |
CRWD | CROWDSTRIKE HLDGS INC | 15 | 15 | 1.23% | 2.07% | 3.26% | Q1 2020 | Q3 2023 | 15 |
TT | TRANE TECHNOLOGIES PLC | 15 | 15 | 0.05% | 1.79% | 2.88% | Q1 2020 | Q3 2023 | 15 |
CTAS | CINTAS CORP | 9 | 6 | 0.37% | 1.22% | 2.26% | Q4 2018 | Q3 2022 | 15 |
VMC | VULCAN MATLS CO | 15 | 15 | 0.45% | 0.90% | 1.59% | Q1 2017 | Q3 2020 | 15 |
VRSK | VERISK ANALYTICS INC | 15 | 15 | 0.16% | 0.68% | 1.34% | Q1 2020 | Q3 2023 | 15 |
CGNX | COGNEX CORP | 9 | 6 | 0.33% | 0.48% | 0.81% | Q2 2014 | Q2 2022 | 15 |
CWEN | CLEARWAY ENERGY INC | 12 | 3 | 0.00% | 0.47% | 0.88% | Q3 2018 | Q2 2023 | 15 |
RCKT | ROCKET PHARMACEUTICALS... | 11 | 4 | 0.18% | 0.46% | 0.91% | Q1 2018 | Q3 2023 | 15 |
MDB | MONGODB INC | 13 | 1 | 0.00% | 0.44% | 1.13% | Q3 2019 | Q3 2023 | 15 |
ALNY | ALNYLAM PHARMACEUTICAL... | 15 | 15 | 0.20% | 0.36% | 0.60% | Q1 2015 | Q3 2018 | 15 |
TSRO | TESARO INC | 15 | 15 | 0.05% | 0.32% | 0.57% | Q4 2014 | Q2 2018 | 15 |
SHW | SHERWIN WILLIAMS CO | 15 | 15 | 0.03% | 0.14% | 0.43% | Q1 2020 | Q3 2023 | 15 |
ETTX | ENTASIS THERAPEUTICS H... | 15 | 15 | 0.02% | 0.09% | 0.30% | Q3 2018 | Q1 2022 | 15 |
BDN | BRANDYWINE RLTY TR | 15 | 15 | 0.01% | 0.06% | 0.08% | Q3 2015 | Q1 2019 | 15 |
LXP | LEXINGTON REALTY TRUST | 15 | 15 | 0.00% | 0.02% | 0.03% | Q3 2015 | Q1 2019 | 15 |
AIMT | AIMMUNE THERAPEUTICS INC | 14 | 14 | 0.45% | 1.76% | 2.91% | Q1 2017 | Q2 2020 | 14 |
IDTI | INTEGRATED DEVICE TECH... | 14 | 14 | 1.09% | 1.31% | 1.64% | Q1 2015 | Q2 2018 | 14 |
BWA | BORGWARNER INC | 13 | 1 | 0.03% | 1.07% | 1.94% | Q4 2013 | Q4 2019 | 14 |
ZNTL | ZENTALIS PHARMACEUTICA... | 14 | 14 | 0.30% | 1.00% | 3.28% | Q2 2020 | Q3 2023 | 14 |
ENTG | ENTEGRIS INC | 14 | 14 | 0.02% | 0.89% | 1.70% | Q2 2020 | Q3 2023 | 14 |
AYR | AIRCASTLE LTD | 14 | 14 | 0.45% | 0.78% | 1.90% | Q4 2013 | Q1 2017 | 14 |
CLDX | CELLDEX THERAPEUTICS I... | 14 | 14 | 0.13% | 0.72% | 1.29% | Q2 2020 | Q3 2023 | 14 |
DBVT | DBV TECHNOLOGIES S A | 14 | 14 | 0.14% | 0.38% | 0.57% | Q1 2015 | Q2 2018 | 14 |
CRNX | CRINETICS PHARMACEUTIC... | 11 | 3 | 0.06% | 0.33% | 0.67% | Q3 2018 | Q3 2023 | 14 |
STE | STERIS PLC | 14 | 14 | 0.06% | 0.32% | 0.51% | Q2 2020 | Q3 2023 | 14 |
INSM | INSMED INC | 10 | 4 | 0.12% | 0.20% | 0.32% | Q4 2013 | Q3 2023 | 14 |
FRC | FIRST REP BK SAN FRANC... | 14 | 14 | 0.03% | 0.20% | 0.39% | Q3 2019 | Q4 2022 | 14 |
FENC | FENNEC PHARMACEUTICALS... | 14 | 14 | 0.09% | 0.19% | 0.42% | Q4 2017 | Q1 2021 | 14 |
DRNA | DICERNA PHARMACEUTICAL... | 14 | 14 | 0.07% | 0.14% | 0.26% | Q2 2014 | Q3 2017 | 14 |
JCI | JOHNSON CTLS INTL PLC | 14 | 14 | 0.02% | 0.08% | 0.11% | Q3 2016 | Q4 2019 | 14 |
BG | BUNGE LIMITED | 14 | 14 | 0.01% | 0.05% | 0.08% | Q1 2016 | Q2 2019 | 14 |
WELL | WELLTOWER INC | 13 | 1 | 0.01% | 0.02% | 0.05% | Q4 2015 | Q3 2019 | 14 |
WAB | WABTEC CORP | 13 | 13 | 0.86% | 1.59% | 1.93% | Q4 2013 | Q4 2016 | 13 |
CRUS | CIRRUS LOGIC INC | 13 | 13 | 0.52% | 1.06% | 1.84% | Q4 2015 | Q4 2018 | 13 |
SPT | SPROUT SOCIAL INC | 13 | 13 | 0.71% | 1.05% | 1.60% | Q3 2020 | Q3 2023 | 13 |
MYOV | MYOVANT SCIENCES LTD | 13 | 13 | 0.20% | 1.02% | 2.06% | Q1 2017 | Q1 2020 | 13 |
NVAX | NOVAVAX INC | 13 | 13 | 0.12% | 0.99% | 2.03% | Q4 2013 | Q4 2016 | 13 |
MYOK | MYOKARDIA INC | 13 | 13 | 0.18% | 0.83% | 1.66% | Q3 2017 | Q3 2020 | 13 |
MPWR | MONOLITHIC PWR SYS INC | 13 | 13 | 0.39% | 0.67% | 0.97% | Q3 2020 | Q3 2023 | 13 |
BEPC | BROOKFIELD RENEWABLE CORP | 13 | 13 | 0.33% | 0.47% | 0.68% | Q3 2020 | Q3 2023 | 13 |
LSCC | LATTICE SEMICONDUCTOR ... | 13 | 13 | 0.01% | 0.42% | 0.90% | Q3 2020 | Q3 2023 | 13 |
A | AGILENT TECHNOLOGIES INC | 13 | 13 | 0.05% | 0.41% | 0.91% | Q3 2019 | Q3 2022 | 13 |
BOLD | AUDENTES THERAPEUTICS INC | 13 | 13 | 0.24% | 0.38% | 0.67% | Q3 2016 | Q3 2019 | 13 |
VYGR | VOYAGER THERAPEUTICS INC | 13 | 13 | 0.15% | 0.36% | 0.66% | Q4 2015 | Q4 2018 | 13 |
SNPS | SYNOPSYS INC | 13 | 13 | 0.04% | 0.31% | 0.65% | Q3 2020 | Q3 2023 | 13 |
ELS | EQUITY LIFESTYLE PPTYS... | 11 | 2 | 0.01% | 0.18% | 0.30% | Q1 2020 | Q3 2023 | 13 |
SYY | SYSCO CORP | 13 | 13 | 0.04% | 0.17% | 0.29% | Q3 2020 | Q3 2023 | 13 |
OMED | ONCOMED PHARMACEUTICAL... | 13 | 13 | 0.10% | 0.16% | 0.28% | Q4 2013 | Q4 2016 | 13 |
SEP | SPECTRA ENERGY PARTNER... | 13 | 13 | 0.01% | 0.08% | 0.14% | Q3 2015 | Q3 2018 | 13 |
APU | AMERIGAS PARTNERS L P | 9 | 4 | 0.01% | 0.04% | 0.06% | Q1 2016 | Q2 2019 | 13 |
VTR | VENTAS INC | 10 | 1 | 0.01% | 0.03% | 0.06% | Q1 2016 | Q3 2019 | 13 |
CPN | CALPINE CORP | 12 | 12 | 0.39% | 1.34% | 1.81% | Q4 2013 | Q3 2016 | 12 |
INST | INSTRUCTURE INC | 12 | 12 | 0.42% | 1.17% | 1.86% | Q4 2016 | Q3 2019 | 12 |
IMVT | IMMUNOVANT INC | 12 | 12 | 0.33% | 0.58% | 1.29% | Q2 2020 | Q1 2023 | 12 |
ONCE | SPARK THERAPEUTICS INC | 12 | 12 | 0.12% | 0.56% | 1.64% | Q2 2015 | Q1 2018 | 12 |
WVE | WAVE LIFE SCIENCES LTD | 12 | 12 | 0.23% | 0.55% | 0.79% | Q2 2016 | Q1 2019 | 12 |
MASS | 908 DEVICES INC | 12 | 12 | 0.17% | 0.34% | 0.66% | Q4 2020 | Q3 2023 | 12 |
ADCT | ADC THERAPEUTICS SA | 12 | 12 | 0.06% | 0.33% | 0.53% | Q2 2020 | Q1 2023 | 12 |
AGTC | APPLIED GENETIC TECHNO... | 12 | 12 | 0.08% | 0.29% | 0.65% | Q2 2014 | Q1 2017 | 12 |
PNR | PENTAIR PLC | 12 | 12 | 0.08% | 0.27% | 0.38% | Q4 2020 | Q3 2023 | 12 |
CEMP | CEMPRA INC | 12 | 12 | 0.18% | 0.27% | 0.40% | Q4 2013 | Q3 2016 | 12 |
NDAQ | NASDAQ INC | 11 | 1 | 0.02% | 0.25% | 0.57% | Q2 2020 | Q2 2023 | 12 |
FHB | FIRST HAWAIIAN INC | 12 | 12 | 0.02% | 0.08% | 0.12% | Q3 2016 | Q2 2019 | 12 |
HMC | HONDA MOTOR LTD | 11 | 1 | 0.01% | 0.08% | 0.10% | Q3 2016 | Q3 2019 | 12 |
ZTS | ZOETIS INC | 8 | 1 | 0.01% | 0.05% | 0.09% | Q4 2019 | Q3 2023 | 12 |
NYLD | NRG YIELD INC | 12 | 12 | 0.00% | 0.05% | 0.08% | Q3 2015 | Q2 2018 | 12 |
ZGNX | ZOGENIX INC | 11 | 11 | 0.35% | 2.30% | 4.17% | Q4 2017 | Q2 2020 | 11 |
MDVN | MEDIVATION INC | 11 | 11 | 0.55% | 1.97% | 3.80% | Q4 2013 | Q2 2016 | 11 |
CBI | CHICAGO BRIDGE & IRON ... | 11 | 11 | 0.95% | 1.49% | 2.65% | Q4 2013 | Q2 2016 | 11 |
ZI | ZOOMINFO TECHNOLOGIES INC | 11 | 11 | 0.00% | 1.47% | 2.08% | Q3 2020 | Q1 2023 | 11 |
LLTC | LINEAR TECHNOLOGY CORP | 11 | 11 | 0.62% | 1.26% | 2.06% | Q4 2013 | Q2 2016 | 11 |
UFS | DOMTAR CORP | 11 | 11 | 0.43% | 1.09% | 2.25% | Q4 2013 | Q2 2016 | 11 |
CAFD | 8POINT3 ENERGY PARTNER... | 11 | 11 | 0.21% | 1.07% | 1.39% | Q3 2015 | Q1 2018 | 11 |
MGTA | MAGENTA THERAPEUTICS INC | 11 | 11 | 0.12% | 0.88% | 1.71% | Q2 2018 | Q4 2020 | 11 |
SMAR | SMARTSHEET INC | 11 | 11 | 0.41% | 0.80% | 1.27% | Q3 2019 | Q1 2022 | 11 |
AVRO | AVROBIO INC | 11 | 11 | 0.28% | 0.76% | 1.70% | Q2 2018 | Q4 2020 | 11 |
ROL | ROLLINS INC | 7 | 1 | 0.33% | 0.68% | 1.45% | Q3 2016 | Q3 2023 | 11 |
SHLS | SHOALS TECHNOLOGIES GR... | 11 | 11 | 0.17% | 0.57% | 1.06% | Q1 2021 | Q3 2023 | 11 |
PAYC | PAYCOM SOFTWARE INC | 10 | 1 | 0.01% | 0.54% | 0.98% | Q3 2017 | Q1 2021 | 11 |
ANNX | ANNEXON INC | 11 | 11 | 0.13% | 0.52% | 1.03% | Q3 2020 | Q1 2023 | 11 |
SNDX | SYNDAX PHARMACEUTICALS... | 9 | 2 | 0.08% | 0.29% | 0.67% | Q2 2017 | Q1 2022 | 11 |
ETNB | 89BIO INC | 9 | 2 | 0.12% | 0.27% | 0.44% | Q4 2019 | Q2 2023 | 11 |
PHAT | PHATHOM PHARMACEUTICAL... | 11 | 11 | 0.06% | 0.25% | 0.40% | Q4 2019 | Q2 2022 | 11 |
FRLN | FREELINE THERAPEUTICS ... | 11 | 11 | 0.04% | 0.24% | 0.70% | Q3 2020 | Q1 2023 | 11 |
INCY | INCYTE CORP | 11 | 11 | 0.12% | 0.24% | 0.35% | Q1 2016 | Q3 2018 | 11 |
TGTX | TG THERAPEUTICS INC | 11 | 11 | 0.16% | 0.23% | 0.32% | Q2 2014 | Q4 2016 | 11 |
CDTX | CIDARA THERAPEUTICS INC | 11 | 11 | 0.06% | 0.15% | 0.23% | Q2 2015 | Q4 2017 | 11 |
NEE | NEXTERA ENERGY INC | 6 | 2 | 0.00% | 0.06% | 0.14% | Q2 2019 | Q2 2023 | 11 |
WBK | WESTPAC BKG CORP | 11 | 11 | 0.00% | 0.03% | 0.05% | Q3 2015 | Q1 2018 | 11 |
RHT | RED HAT INC | 10 | 10 | 1.91% | 2.37% | 2.85% | Q4 2013 | Q1 2016 | 10 |
DT | DYNATRACE INC | 10 | 10 | 0.59% | 1.82% | 2.56% | Q4 2019 | Q1 2022 | 10 |
CYBR | CYBERARK SOFTWARE LTD | 10 | 10 | 0.80% | 1.75% | 2.30% | Q2 2015 | Q3 2017 | 10 |
PTLA | PORTOLA PHARMACEUTICAL... | 10 | 10 | 0.45% | 1.18% | 1.48% | Q4 2013 | Q1 2016 | 10 |
VRNS | VARONIS SYS INC | 10 | 10 | 0.42% | 1.11% | 1.96% | Q4 2017 | Q1 2020 | 10 |
LGND | LIGAND PHARMACEUTICALS... | 10 | 10 | 0.43% | 0.96% | 2.18% | Q4 2013 | Q1 2016 | 10 |
XMTR | XOMETRY INC | 10 | 10 | 0.02% | 0.93% | 1.80% | Q2 2021 | Q3 2023 | 10 |
DOOR | MASONITE INTL CORP NEW | 10 | 10 | 0.34% | 0.86% | 1.64% | Q3 2016 | Q4 2018 | 10 |
MNTA | MOMENTA PHARMACEUTICAL... | 10 | 10 | 0.34% | 0.70% | 1.07% | Q1 2018 | Q2 2020 | 10 |
NVT | NVENT ELECTRIC PLC | 10 | 10 | 0.24% | 0.53% | 0.75% | Q2 2021 | Q3 2023 | 10 |
REGN | REGENERON PHARMACEUTICALS | 6 | 4 | 0.15% | 0.31% | 0.49% | Q2 2017 | Q4 2020 | 10 |
TCON | TRACON PHARMACEUTICALS... | 10 | 10 | 0.13% | 0.20% | 0.28% | Q3 2015 | Q4 2017 | 10 |
SYRS | SYROS PHARMACEUTICALS INC | 10 | 10 | 0.06% | 0.11% | 0.17% | Q2 2016 | Q3 2018 | 10 |
TNDM | TANDEM DIABETES CARE INC | 10 | 10 | 0.04% | 0.11% | 0.18% | Q3 2014 | Q4 2016 | 10 |
RXDX | PROMETHEUS BIOSCIENCES... | 9 | 9 | 0.97% | 1.74% | 3.10% | Q1 2021 | Q1 2023 | 9 |
SYNA | SYNAPTICS INC | 9 | 9 | 1.28% | 1.64% | 1.87% | Q2 2014 | Q2 2016 | 9 |
DATA | TABLEAU SOFTWARE INC | 9 | 9 | 0.81% | 1.57% | 2.14% | Q2 2014 | Q2 2016 | 9 |
DLO | DLOCAL LTD | 9 | 9 | 0.36% | 1.55% | 2.00% | Q3 2021 | Q3 2023 | 9 |
EOG | EOG RES INC | 9 | 9 | 0.51% | 1.41% | 2.30% | Q4 2013 | Q4 2015 | 9 |
GLBE | GLOBAL E ONLINE LTD | 9 | 9 | 0.45% | 1.34% | 1.75% | Q3 2021 | Q3 2023 | 9 |
GH | GUARDANT HEALTH INC | 9 | 9 | 0.29% | 1.34% | 2.42% | Q3 2021 | Q3 2023 | 9 |
SNA | SNAP ON INC | 9 | 9 | 0.62% | 1.25% | 1.79% | Q3 2016 | Q3 2018 | 9 |
ARW | ARROW ELECTRS INC | 9 | 9 | 0.92% | 1.23% | 1.44% | Q2 2016 | Q2 2018 | 9 |
GNRC | GENERAC HLDGS INC | 8 | 1 | 0.00% | 1.18% | 1.76% | Q4 2020 | Q1 2023 | 9 |
SCTY | SOLARCITY CORP | 9 | 9 | 0.52% | 1.06% | 2.00% | Q4 2013 | Q4 2015 | 9 |
PRAX | PRAXIS PRECISION MEDIC... | 9 | 9 | 0.16% | 0.94% | 2.82% | Q4 2020 | Q4 2022 | 9 |
COUR | COURSERA INC | 9 | 9 | 0.33% | 0.74% | 1.24% | Q3 2021 | Q3 2023 | 9 |
CLDX | CELLDEX THERAPEUTICS I... | 9 | 9 | 0.14% | 0.66% | 1.92% | Q4 2013 | Q4 2015 | 9 |
OKTA | OKTA INC | 9 | 9 | 0.32% | 0.44% | 0.56% | Q1 2019 | Q1 2021 | 9 |
ALLK | ALLAKOS INC | 8 | 1 | 0.01% | 0.37% | 0.88% | Q3 2018 | Q4 2021 | 9 |
WMB | WILLIAMS COS INC DEL | 8 | 1 | 0.05% | 0.36% | 0.50% | Q3 2019 | Q3 2023 | 9 |
CCXI | CHEMOCENTRYX INC | 9 | 9 | 0.22% | 0.33% | 0.48% | Q2 2020 | Q2 2022 | 9 |
ICPT | INTERCEPT PHARMACEUTIC... | 6 | 1 | 0.07% | 0.33% | 0.79% | Q4 2018 | Q1 2023 | 9 |
RARX | RA PHARMACEUTICALS INC | 7 | 2 | 0.08% | 0.28% | 0.68% | Q2 2017 | Q3 2019 | 9 |
ESI | ELEMENT SOLUTIONS INC | 9 | 9 | 0.13% | 0.27% | 0.37% | Q3 2021 | Q3 2023 | 9 |
DVAX | DYNAVAX TECHNOLOGIES CORP | 7 | 2 | 0.16% | 0.27% | 0.40% | Q1 2015 | Q3 2023 | 9 |
ESSA PHARMA INC | 9 | 9 | 0.03% | 0.26% | 0.49% | Q1 2016 | Q1 2018 | 9 | |
BRKR | BRUKER CORP | 5 | 4 | 0.16% | 0.24% | 0.32% | Q4 2013 | Q3 2023 | 9 |
CMS | CMS ENERGY CORP | 6 | 3 | 0.07% | 0.22% | 0.41% | Q4 2019 | Q3 2023 | 9 |
GXO LOGISTICS INCORPOR... | 9 | 9 | 0.15% | 0.22% | 0.26% | Q3 2021 | Q3 2023 | 9 | |
CIEN | CIENA CORP | 9 | 9 | 0.03% | 0.20% | 0.31% | Q2 2020 | Q2 2022 | 9 |
TERP | TERRAFORM PWR INC | 5 | 4 | 0.00% | 0.13% | 1.03% | Q3 2015 | Q4 2017 | 9 |
EQIX | EQUINIX INC | 6 | 1 | 0.03% | 0.10% | 0.19% | Q3 2019 | Q3 2023 | 9 |
MLHR | MILLER HERMAN INC | 9 | 9 | 0.01% | 0.05% | 0.07% | Q4 2017 | Q4 2019 | 9 |
GLBL | TERRAFORM GLOBAL INC | 9 | 9 | 0.00% | 0.05% | 0.26% | Q3 2015 | Q3 2017 | 9 |
MBBYF | MOBILEYE N V AMSTELVEEN | 8 | 8 | 1.56% | 2.08% | 2.47% | Q1 2015 | Q4 2016 | 8 |
SUNEQ | SUNEDISON INC | 8 | 8 | 1.18% | 1.92% | 2.55% | Q4 2013 | Q3 2015 | 8 |
DYAX | DYAX CORP | 8 | 8 | 1.61% | 1.88% | 2.40% | Q4 2013 | Q3 2015 | 8 |
ININ | INTERACTIVE INTELLIGEN... | 8 | 8 | 0.31% | 0.96% | 1.92% | Q4 2013 | Q3 2015 | 8 |
LNG | CHENIERE ENERGY INC | 8 | 8 | 0.08% | 0.86% | 1.32% | Q4 2021 | Q3 2023 | 8 |
CMRE | COSTAMARE INC | 8 | 8 | 0.26% | 0.78% | 1.20% | Q4 2013 | Q3 2015 | 8 |
SGMO | SANGAMO BIOSCIENCES INC | 8 | 8 | 0.16% | 0.72% | 1.30% | Q4 2013 | Q3 2015 | 8 |
PWR | QUANTA SVCS INC | 8 | 8 | 0.33% | 0.63% | 0.93% | Q4 2013 | Q3 2015 | 8 |
YETI | YETI HLDGS INC | 8 | 8 | 0.21% | 0.60% | 0.85% | Q4 2020 | Q3 2022 | 8 |
COGT | COGENT BIOSCIENCES INC | 8 | 8 | 0.38% | 0.60% | 0.98% | Q4 2021 | Q3 2023 | 8 |
BCYC | BICYCLE THERAPEUTICS PLC | 8 | 8 | 0.18% | 0.54% | 0.98% | Q1 2021 | Q4 2022 | 8 |
AYI | ACUITY BRANDS INC | 8 | 8 | 0.02% | 0.54% | 1.50% | Q3 2016 | Q2 2018 | 8 |
KITE | KITE PHARMA INC | 8 | 8 | 0.37% | 0.48% | 0.66% | Q3 2015 | Q2 2017 | 8 |
NRIX | NURIX THERAPEUTICS INC | 8 | 8 | 0.31% | 0.47% | 0.69% | Q3 2020 | Q2 2022 | 8 |
KURA | KURA ONCOLOGY INC | 8 | 8 | 0.20% | 0.43% | 0.70% | Q3 2020 | Q2 2022 | 8 |
VECT | VECTIVBIO HLDG AG | 8 | 8 | 0.14% | 0.33% | 0.58% | Q2 2021 | Q1 2023 | 8 |
CSII | CARDIOVASCULAR SYS INC... | 8 | 8 | 0.11% | 0.20% | 0.26% | Q4 2013 | Q3 2015 | 8 |
ROIVANT SCIENCES LTD | 8 | 8 | 0.09% | 0.20% | 0.36% | Q4 2021 | Q3 2023 | 8 | |
BCRX | BIOCRYST PHARMACEUTICA... | 3 | 2 | 0.07% | 0.20% | 0.37% | Q2 2017 | Q3 2023 | 8 |
ZSAN | ZOSANO PHARMA CORP | 8 | 8 | 0.01% | 0.19% | 0.63% | Q1 2015 | Q4 2016 | 8 |
TALS | TALARIS THERAPEUTICS INC | 8 | 8 | 0.03% | 0.18% | 0.30% | Q2 2021 | Q1 2023 | 8 |
SNV | SYNOVUS FINL CORP | 8 | 8 | 0.08% | 0.16% | 0.27% | Q1 2021 | Q4 2022 | 8 |
PALO ALTO NETWORKS INC | 6 | 2 | 0.06% | 0.15% | 0.25% | Q3 2019 | Q1 2022 | 8 | |
EGP | EASTGROUP PPTYS INC | 8 | 8 | 0.09% | 0.14% | 0.20% | Q4 2021 | Q3 2023 | 8 |
ARAY | ACCURAY INC | 4 | 4 | 0.09% | 0.13% | 0.26% | Q1 2015 | Q1 2017 | 8 |
MDSO | MEDIDATA SOLUTIONS INC | 8 | 8 | 0.05% | 0.11% | 0.26% | Q4 2013 | Q3 2015 | 8 |
FHN | FIRST HORIZON NATL CORP | 6 | 2 | 0.04% | 0.11% | 0.22% | Q3 2019 | Q3 2021 | 8 |
HANNON ARMSTRONG SUST ... | 8 | 8 | 0.05% | 0.06% | 0.08% | Q3 2017 | Q2 2019 | 8 | |
HTGC | HERCULES TECH GROWTH C... | 8 | 8 | 0.01% | 0.06% | 0.10% | Q3 2015 | Q2 2017 | 8 |
CCIPRA | CROWN CASTLE INTL CORP... | 7 | 1 | 0.01% | 0.05% | 0.06% | Q3 2017 | Q1 2020 | 8 |
ARTERIS INC | 8 | 8 | 0.03% | 0.04% | 0.05% | Q4 2021 | Q3 2023 | 8 | |
SLAB | SILICON LABORATORIES INC | 8 | 8 | 0.01% | 0.03% | 0.06% | Q3 2020 | Q2 2022 | 8 |
ACORDA THERAPEUTICS INC | 8 | 8 | 0.01% | 0.02% | 0.02% | Q2 2017 | Q1 2019 | 8 | |
CMRX | CHIMERIX INC | 7 | 7 | 1.19% | 1.41% | 1.84% | Q1 2014 | Q3 2015 | 7 |
NRG | NRG ENERGY INC | 7 | 7 | 0.96% | 1.28% | 1.71% | Q4 2013 | Q2 2015 | 7 |
PLRX | PLIANT THERAPEUTICS INC | 7 | 7 | 0.01% | 1.00% | 1.92% | Q2 2020 | Q4 2021 | 7 |
RNG | RINGCENTRAL INC | 7 | 7 | 0.42% | 0.93% | 1.26% | Q1 2020 | Q3 2021 | 7 |
ZYME | ZYMEWORKS INC | 7 | 7 | 0.55% | 0.85% | 1.49% | Q1 2021 | Q3 2022 | 7 |
ANET | ARISTA NETWORKS INC | 7 | 7 | 0.64% | 0.84% | 1.27% | Q1 2018 | Q3 2019 | 7 |
VITL | VITAL FARMS INC | 7 | 7 | 0.18% | 0.65% | 0.97% | Q4 2020 | Q2 2022 | 7 |
SWKS | SKYWORKS SOLUTIONS INC | 7 | 7 | 0.33% | 0.40% | 0.45% | Q1 2020 | Q3 2021 | 7 |
TRGP | TARGA RES CORP | 7 | 7 | 0.04% | 0.34% | 0.88% | Q1 2022 | Q3 2023 | 7 |
CSLT | CASTLIGHT HEALTH INC | 7 | 7 | 0.19% | 0.33% | 0.43% | Q2 2015 | Q4 2016 | 7 |
WEC | WEC ENERGY GROUP INC | 5 | 2 | 0.06% | 0.24% | 0.41% | Q1 2020 | Q1 2023 | 7 |
SAAS | INCONTACT INC | 7 | 7 | 0.08% | 0.24% | 0.46% | Q4 2013 | Q2 2015 | 7 |
ACRS | ACLARIS THERAPEUTICS INC | 7 | 7 | 0.12% | 0.23% | 0.39% | Q3 2016 | Q1 2018 | 7 |
EPZM | EPIZYME INC | 7 | 7 | 0.16% | 0.23% | 0.31% | Q1 2016 | Q3 2017 | 7 |
AESC | AES CORP | 7 | 7 | 0.12% | 0.23% | 0.34% | Q2 2021 | Q4 2022 | 7 |
LW | LAMB WESTON HLDGS INC | 7 | 7 | 0.02% | 0.22% | 0.45% | Q3 2019 | Q1 2021 | 7 |
SNSS | SUNESIS PHARMACEUTICAL... | 7 | 7 | 0.00% | 0.20% | 0.44% | Q3 2017 | Q1 2019 | 7 |
CHRS | COHERUS BIOSCIENCES INC | 7 | 7 | 0.11% | 0.18% | 0.27% | Q1 2016 | Q3 2017 | 7 |
DERM | DERMIRA INC | 7 | 7 | 0.11% | 0.16% | 0.22% | Q2 2017 | Q4 2018 | 7 |
FEIC | FEI CO | 7 | 7 | 0.07% | 0.15% | 0.24% | Q4 2013 | Q2 2015 | 7 |
PTCT | PTC THERAPEUTICS INC | 6 | 1 | 0.03% | 0.13% | 0.42% | Q3 2017 | Q1 2023 | 7 |
CTMX | CYTOMX THERAPEUTICS INC | 7 | 7 | 0.09% | 0.12% | 0.17% | Q4 2015 | Q2 2017 | 7 |
IMDZ | IMMUNE DESIGN CORP | 7 | 7 | 0.08% | 0.12% | 0.18% | Q1 2015 | Q3 2016 | 7 |
XOMA | XOMA CORP DEL | 7 | 7 | 0.03% | 0.12% | 0.25% | Q4 2013 | Q2 2015 | 7 |
PHVS | PHARVARIS N V | 7 | 7 | 0.05% | 0.12% | 0.21% | Q1 2021 | Q3 2022 | 7 |
MSCI | MSCI INC | 5 | 2 | 0.03% | 0.11% | 0.27% | Q2 2020 | Q3 2023 | 7 |
GRMN | GARMIN LTD | 7 | 7 | 0.04% | 0.09% | 0.12% | Q4 2020 | Q2 2022 | 7 |
AWK | AMERICAN WTR WKS CO IN... | 7 | 7 | 0.07% | 0.08% | 0.10% | Q2 2020 | Q4 2021 | 7 |
JKHY | HENRY JACK & ASSOC INC | 7 | 7 | 0.04% | 0.07% | 0.11% | Q1 2020 | Q3 2021 | 7 |
TERP | TERRAFORM PWR INC | 7 | 7 | 0.04% | 0.07% | 0.09% | Q1 2018 | Q3 2019 | 7 |
WM | WASTE MGMT INC DEL | 6 | 1 | 0.01% | 0.06% | 0.09% | Q2 2019 | Q3 2023 | 7 |
RPTP | RAPTOR PHARMACEUTICAL ... | 7 | 7 | 0.01% | 0.06% | 0.16% | Q4 2013 | Q2 2015 | 7 |
NEUROCRINE BIOSCIENCES... | 7 | 7 | 0.02% | 0.05% | 0.06% | Q3 2019 | Q1 2021 | 7 | |
OM | OUTSET MED INC | 7 | 7 | 0.01% | 0.03% | 0.05% | Q3 2020 | Q1 2022 | 7 |
FLYW | FLYWIRE CORPORATION | 6 | 6 | 0.05% | 1.57% | 2.33% | Q2 2022 | Q3 2023 | 6 |
FVRR | FIVERR INTL LTD | 6 | 6 | 0.64% | 1.46% | 1.76% | Q2 2020 | Q3 2021 | 6 |
HZNP | HORIZON THERAPEUTICS P... | 6 | 6 | 0.12% | 1.30% | 2.24% | Q2 2022 | Q3 2023 | 6 |
TEX | TEREX CORP NEW | 6 | 6 | 0.70% | 1.24% | 2.09% | Q1 2014 | Q2 2015 | 6 |
OII | OCEANEERING INTL INC | 6 | 6 | 0.53% | 1.09% | 1.99% | Q4 2013 | Q1 2015 | 6 |
TRILLIUM THERAPEUTICS INC | 6 | 6 | 0.45% | 1.01% | 1.24% | Q2 2020 | Q3 2021 | 6 | |
FC | FRANKLIN COVEY CO | 6 | 6 | 0.33% | 0.89% | 1.66% | Q4 2013 | Q1 2015 | 6 |
NLNK | NEWLINK GENETICS CORP | 6 | 6 | 0.64% | 0.88% | 1.07% | Q4 2013 | Q1 2015 | 6 |
EVH | EVOLENT HEALTH INC | 6 | 6 | 0.14% | 0.85% | 1.35% | Q2 2022 | Q3 2023 | 6 |
TPTX | TURNING POINT THERAPEU... | 6 | 6 | 0.51% | 0.68% | 1.09% | Q2 2020 | Q3 2021 | 6 |
SWAV | SHOCKWAVE MED INC | 6 | 6 | 0.10% | 0.65% | 1.27% | Q2 2022 | Q3 2023 | 6 |
ENPH | ENPHASE ENERGY INC | 6 | 6 | 0.16% | 0.62% | 0.89% | Q4 2021 | Q1 2023 | 6 |
AZPN | ASPEN TECHNOLOGY INC | 6 | 6 | 0.20% | 0.54% | 0.84% | Q1 2014 | Q2 2015 | 6 |
CDW | CDW CORP | 6 | 6 | 0.28% | 0.50% | 0.61% | Q2 2022 | Q3 2023 | 6 |
KALA | KALA PHARMACEUTICALS INC | 5 | 1 | 0.08% | 0.49% | 0.84% | Q3 2017 | Q1 2021 | 6 |
NARI | INARI MED INC | 6 | 6 | 0.09% | 0.43% | 0.60% | Q2 2022 | Q3 2023 | 6 |
INSP | INSPIRE MED SYS INC | 6 | 6 | 0.09% | 0.40% | 0.59% | Q2 2022 | Q3 2023 | 6 |
PRVA | PRIVIA HEALTH GROUP INC | 6 | 6 | 0.17% | 0.38% | 0.51% | Q2 2022 | Q3 2023 | 6 |
IRTC | IRHYTHM TECHNOLOGIES INC | 6 | 6 | 0.07% | 0.37% | 0.54% | Q2 2022 | Q3 2023 | 6 |
IFRX | INFLARX NV | 6 | 6 | 0.30% | 0.36% | 0.44% | Q4 2017 | Q1 2019 | 6 |
KROS | KEROS THERAPEUTICS INC | 3 | 3 | 0.24% | 0.33% | 0.39% | Q4 2020 | Q3 2023 | 6 |
ARYAU | ARYA SCIENCES ACQUISIT... | 6 | 6 | 0.26% | 0.29% | 0.36% | Q4 2018 | Q1 2020 | 6 |
VBIV | VBI VACCINES INC | 6 | 6 | 0.12% | 0.22% | 0.41% | Q4 2017 | Q1 2019 | 6 |
JUNO | JUNO THERAPEUTICS INC | 6 | 6 | 0.11% | 0.17% | 0.21% | Q4 2015 | Q1 2017 | 6 |
IRWD | IRONWOOD PHARMACEUTICA... | 6 | 6 | 0.13% | 0.16% | 0.23% | Q2 2017 | Q3 2018 | 6 |
PCRX | PACIRA PHARMACEUTICALS... | 6 | 6 | 0.09% | 0.16% | 0.24% | Q4 2013 | Q1 2015 | 6 |
AQXP | AQUINOX PHARMACEUTICAL... | 6 | 6 | 0.11% | 0.15% | 0.19% | Q4 2016 | Q1 2018 | 6 |
ORTX | ORCHARD THERAPEUTICS PLC | 6 | 6 | 0.07% | 0.12% | 0.19% | Q4 2018 | Q1 2020 | 6 |
DSGN | DESIGN THERAPEUTICS INC | 6 | 6 | 0.08% | 0.11% | 0.18% | Q1 2021 | Q2 2022 | 6 |
INFI | INFINITY PHARMACEUTICA... | 6 | 6 | 0.07% | 0.11% | 0.18% | Q4 2014 | Q1 2016 | 6 |
CBIO | CATALYST BIOSCIENCES INC | 6 | 6 | 0.08% | 0.10% | 0.13% | Q2 2018 | Q3 2019 | 6 |
TFX | TELEFLEX INC | 6 | 6 | 0.05% | 0.09% | 0.17% | Q4 2013 | Q1 2015 | 6 |
FOUR | SHIFT4 PMTS INC | 6 | 6 | 0.04% | 0.06% | 0.07% | Q4 2020 | Q1 2022 | 6 |
ZBH | ZIMMER BIOMET HOLDINGS... | 6 | 6 | 0.05% | 0.05% | 0.07% | Q4 2019 | Q1 2021 | 6 |
IR | INGERSOLL-RAND PLC | 4 | 2 | 0.02% | 0.05% | 0.08% | Q2 2018 | Q4 2019 | 6 |
CVA | COVANTA HLDG CORP | 6 | 6 | 0.02% | 0.04% | 0.05% | Q4 2017 | Q1 2019 | 6 |
GPMT | GRANITE PT MTG TR INC | 5 | 1 | 0.01% | 0.04% | 0.06% | Q1 2018 | Q3 2019 | 6 |
NXPI | NXP SEMICONDUCTORS N V | 3 | 1 | 0.00% | 0.03% | 0.05% | Q1 2019 | Q4 2022 | 6 |
CIG | COMPANHIA ENERGETICA D... | 6 | 6 | 0.01% | 0.03% | 0.04% | Q4 2017 | Q1 2019 | 6 |
BBN | BLACKROCK TAX MUNICPAL... | 6 | 6 | 0.01% | 0.02% | 0.02% | Q3 2015 | Q4 2016 | 6 |
NSC | NORFOLK SOUTHERN CORP | 6 | 6 | 0.01% | 0.01% | 0.02% | Q3 2015 | Q4 2016 | 6 |
TRW | TRW AUTOMOTIVE HLDGS CORP | 5 | 5 | 2.23% | 2.48% | 2.80% | Q4 2013 | Q4 2014 | 5 |
DOCS | DOXIMITY INC | 5 | 5 | 1.13% | 2.22% | 3.12% | Q2 2022 | Q2 2023 | 5 |
AVXS | AVEXIS INC | 5 | 5 | 0.41% | 1.77% | 2.44% | Q1 2017 | Q1 2018 | 5 |
MEOH | METHANEX CORP | 5 | 5 | 1.01% | 1.76% | 2.21% | Q4 2013 | Q4 2014 | 5 |
XYL | XYLEM INC | 5 | 5 | 1.08% | 1.66% | 2.07% | Q1 2019 | Q1 2020 | 5 |
LYB | LYONDELLBASELL INDUSTR... | 5 | 5 | 1.16% | 1.66% | 2.04% | Q4 2013 | Q4 2014 | 5 |
PCYC | PHARMACYCLICS INC | 5 | 5 | 1.01% | 1.47% | 2.17% | Q4 2013 | Q4 2014 | 5 |
CCI | CROWN CASTLE INTL CORP | 5 | 5 | 1.01% | 1.28% | 1.50% | Q4 2013 | Q4 2014 | 5 |
P103PS | NPS PHARMACEUTICALS INC | 5 | 5 | 0.81% | 1.26% | 2.27% | Q4 2013 | Q4 2014 | 5 |
CXP | COLUMBIA PPTY TR INC | 5 | 5 | 0.80% | 1.20% | 1.42% | Q1 2014 | Q1 2015 | 5 |
MIRM | MIRUM PHARMACEUTICALS INC | 5 | 5 | 0.53% | 1.20% | 2.25% | Q3 2022 | Q3 2023 | 5 |
DV | DOUBLEVERIFY HLDGS INC | 5 | 5 | 0.96% | 1.13% | 1.39% | Q3 2022 | Q3 2023 | 5 |
VMW | VMWARE INC | 5 | 5 | 0.60% | 1.07% | 1.32% | Q1 2014 | Q1 2015 | 5 |
IMMU | IMMUNOMEDICS INC | 5 | 5 | 0.41% | 0.69% | 0.93% | Q2 2018 | Q2 2019 | 5 |
GTTN | GTT COMMUNICATIONS INC | 5 | 5 | 0.10% | 0.58% | 1.17% | Q4 2017 | Q4 2018 | 5 |
FOLD | AMICUS THERAPEUTICS INC | 5 | 5 | 0.31% | 0.58% | 0.76% | Q3 2018 | Q3 2019 | 5 |
SGEN | SEAGEN INC | 4 | 1 | 0.28% | 0.57% | 1.04% | Q4 2020 | Q3 2023 | 5 |
REXR | REXFORD INDL RLTY INC | 5 | 5 | 0.14% | 0.45% | 0.70% | Q3 2021 | Q3 2022 | 5 |
CGEM | CULLINAN ONCOLOGY INC | 5 | 5 | 0.24% | 0.43% | 0.73% | Q1 2021 | Q1 2022 | 5 |
BBIO | BRIDGEBIO PHARMA INC | 3 | 2 | 0.27% | 0.43% | 0.65% | Q1 2021 | Q3 2023 | 5 |
VKTX | VIKING THERAPEUTICS INC | 3 | 2 | 0.15% | 0.41% | 0.60% | Q3 2018 | Q3 2023 | 5 |
MAX | MEDIAALPHA INC | 5 | 5 | 0.04% | 0.35% | 0.67% | Q4 2020 | Q4 2021 | 5 |
ECYT | ENDOCYTE INC | 3 | 2 | 0.15% | 0.34% | 0.86% | Q4 2013 | Q3 2018 | 5 |
AJG | GALLAGHER ARTHUR J & CO | 5 | 5 | 0.11% | 0.34% | 0.44% | Q3 2022 | Q3 2023 | 5 |
EIDX | EIDOS THERAPEUTICS INC | 4 | 1 | 0.14% | 0.33% | 0.64% | Q2 2018 | Q4 2020 | 5 |
NTLA | INTELLIA THERAPEUTICS INC | 5 | 5 | 0.21% | 0.29% | 0.35% | Q3 2022 | Q3 2023 | 5 |
SLXP | SALIX PHARMACEUTICALS INC | 5 | 5 | 0.15% | 0.27% | 0.37% | Q4 2013 | Q4 2014 | 5 |
DCPH | DECIPHERA PHARMACEUTIC... | 4 | 1 | 0.18% | 0.26% | 0.32% | Q1 2020 | Q3 2021 | 5 |
HPTX | HYPERION THERAPEUTICS INC | 5 | 5 | 0.19% | 0.24% | 0.29% | Q4 2013 | Q4 2014 | 5 |
MCRB | SERES THERAPEUTICS INC | 5 | 5 | 0.13% | 0.24% | 0.32% | Q3 2015 | Q3 2016 | 5 |
KNSA | KINIKSA PHARMACEUTICAL... | 5 | 5 | 0.02% | 0.22% | 0.40% | Q2 2018 | Q2 2019 | 5 |
BEAM | BEAM THERAPEUTICS INC | 5 | 5 | 0.11% | 0.22% | 0.26% | Q3 2022 | Q3 2023 | 5 |
COMP | COMPASS INC | 3 | 2 | 0.01% | 0.21% | 0.54% | Q2 2021 | Q3 2023 | 5 |
EHC | ENCOMPASS HEALTH CORP | 5 | 5 | 0.17% | 0.20% | 0.23% | Q3 2022 | Q3 2023 | 5 |
KPTI | KARYOPHARM THERAPEUTIC... | 5 | 5 | 0.12% | 0.20% | 0.32% | Q4 2013 | Q4 2014 | 5 |
CRDF | CARDIFF ONCOLOGY INC | 5 | 5 | 0.06% | 0.18% | 0.32% | Q1 2021 | Q1 2022 | 5 |
ACRX | ACELRX PHARMACEUTICALS... | 5 | 5 | 0.10% | 0.17% | 0.26% | Q4 2013 | Q4 2014 | 5 |
ALXO | ALX ONCOLOGY HLDGS INC | 3 | 2 | 0.06% | 0.17% | 0.32% | Q1 2021 | Q1 2023 | 5 |
LOB | LIVE OAK BANCSHARES INC | 5 | 5 | 0.05% | 0.15% | 0.30% | Q2 2021 | Q2 2022 | 5 |
MEIP | MEI PHARMA INC | 5 | 5 | 0.01% | 0.15% | 0.24% | Q4 2013 | Q4 2014 | 5 |
PTGX | PROTAGONIST THERAPEUTI... | 3 | 2 | 0.09% | 0.15% | 0.30% | Q2 2017 | Q3 2023 | 5 |
PTI | PROTEOSTASIS THERAPEUT... | 5 | 5 | 0.06% | 0.14% | 0.21% | Q1 2016 | Q1 2017 | 5 |
SBNY | SIGNATURE BK NEW YORK N Y | 5 | 5 | 0.05% | 0.13% | 0.20% | Q4 2020 | Q4 2021 | 5 |
SBAC | SBA COMMUNICATIONS COR... | 5 | 5 | 0.07% | 0.10% | 0.15% | Q4 2020 | Q4 2021 | 5 |
BOLT | BOLT BIOTHERAPEUTICS INC | 5 | 5 | 0.04% | 0.10% | 0.16% | Q1 2021 | Q1 2022 | 5 |
RGLS | REGULUS THERAPEUTICS INC | 5 | 5 | 0.06% | 0.10% | 0.15% | Q4 2014 | Q4 2015 | 5 |
IONS | IONIS PHARMACEUTICALS INC | 5 | 5 | 0.07% | 0.08% | 0.10% | Q2 2022 | Q2 2023 | 5 |
WMS | ADVANCED DRAIN SYS INC... | 5 | 5 | 0.02% | 0.08% | 0.11% | Q3 2021 | Q3 2022 | 5 |
KBH | KB HOME | 5 | 5 | 0.02% | 0.07% | 0.09% | Q2 2021 | Q2 2022 | 5 |
EXACT SCIENCES CORP | 5 | 5 | 0.03% | 0.06% | 0.07% | Q1 2020 | Q1 2021 | 5 | |
CPPL | COLUMBIA PIPELINE PART... | 5 | 5 | 0.01% | 0.03% | 0.06% | Q4 2015 | Q4 2016 | 5 |
VSTM | VERASTEM INC | 5 | 5 | 0.00% | 0.02% | 0.03% | Q2 2014 | Q2 2015 | 5 |
DOCU | DOCUSIGN INC | 5 | 5 | 0.01% | 0.02% | 0.02% | Q3 2020 | Q3 2021 | 5 |
NVDA | NVIDIA CORPORATION | 4 | 1 | 0.00% | 0.01% | 0.02% | Q3 2019 | Q3 2023 | 5 |
QLIK | QLIK TECHNOLOGIES INC | 4 | 4 | 0.99% | 1.57% | 2.08% | Q2 2015 | Q1 2016 | 4 |
KNBE | KNOWBE4 INC | 4 | 4 | 0.85% | 1.28% | 1.52% | Q4 2021 | Q3 2022 | 4 |
SPWR | SUNPOWER CORP | 4 | 4 | 0.75% | 1.11% | 1.50% | Q3 2015 | Q2 2016 | 4 |
ELLI | ELLIE MAE INC | 4 | 4 | 1.04% | 1.08% | 1.13% | Q3 2017 | Q2 2018 | 4 |
IMPV | IMPERVA INC | 4 | 4 | 0.91% | 1.08% | 1.21% | Q2 2015 | Q1 2016 | 4 |
ORA | ORMAT TECHNOLOGIES INC | 4 | 4 | 0.27% | 0.62% | 0.82% | Q4 2015 | Q3 2016 | 4 |
DICE THERAPEUTICS INC | 4 | 4 | 0.44% | 0.59% | 0.78% | Q3 2021 | Q2 2022 | 4 | |
PBYI | PUMA BIOTECHNOLOGY INC | 2 | 2 | 0.10% | 0.58% | 1.34% | Q4 2013 | Q4 2017 | 4 |
RPRX | ROYALTY PHARMA PLC | 4 | 4 | 0.49% | 0.58% | 0.69% | Q4 2022 | Q3 2023 | 4 |
SZYM | SOLAZYME INC | 4 | 4 | 0.20% | 0.57% | 0.81% | Q4 2013 | Q3 2014 | 4 |
APLS | APELLIS PHARMACEUTICAL... | 4 | 4 | 0.35% | 0.50% | 0.61% | Q3 2022 | Q2 2023 | 4 |
AURA BIOSCIENCES INC | 4 | 4 | 0.43% | 0.50% | 0.61% | Q4 2022 | Q3 2023 | 4 | |
MARINUS PHARMACEUTICAL... | 4 | 4 | 0.25% | 0.47% | 0.66% | Q4 2022 | Q3 2023 | 4 | |
STSA | SATSUMA PHARMACEUTICAL... | 4 | 4 | 0.21% | 0.43% | 0.67% | Q3 2019 | Q2 2020 | 4 |
SLDB | SOLID BIOSCIENCES INC | 3 | 1 | 0.09% | 0.38% | 0.69% | Q1 2018 | Q1 2021 | 4 |
ORLY | OREILLY AUTOMOTIVE INC | 4 | 4 | 0.00% | 0.37% | 0.50% | Q4 2022 | Q3 2023 | 4 |
CYTK | CYTOKINETICS INC | 4 | 4 | 0.29% | 0.37% | 0.50% | Q4 2022 | Q3 2023 | 4 |
BILL | BILL HOLDINGS INC | 3 | 1 | 0.03% | 0.34% | 0.57% | Q3 2022 | Q3 2023 | 4 |
AMYLYX PHARMACEUTICALS... | 4 | 4 | 0.18% | 0.30% | 0.41% | Q4 2022 | Q3 2023 | 4 | |
CBST | CUBIST PHARMACEUTICALS... | 4 | 4 | 0.25% | 0.28% | 0.31% | Q4 2013 | Q3 2014 | 4 |
TMDX | TRANSMEDICS GROUP INC | 2 | 2 | 0.03% | 0.27% | 0.91% | Q2 2021 | Q3 2023 | 4 |
THOR | SYNTHORX INC | 4 | 4 | 0.16% | 0.24% | 0.31% | Q4 2018 | Q3 2019 | 4 |
IMGN | IMMUNOGEN INC | 2 | 2 | 0.08% | 0.24% | 0.42% | Q4 2021 | Q3 2023 | 4 |
MKC | MCCORMICK & CO INC | 4 | 4 | 0.19% | 0.23% | 0.27% | Q1 2020 | Q4 2020 | 4 |
WDAY | WORKDAY INC | 4 | 4 | 0.01% | 0.22% | 0.51% | Q4 2022 | Q3 2023 | 4 |
ARVN | ARVINAS INC | 3 | 1 | 0.11% | 0.20% | 0.30% | Q1 2020 | Q3 2022 | 4 |
ORIC | ORIC PHARMACEUTICALS INC | 4 | 4 | 0.16% | 0.20% | 0.22% | Q4 2020 | Q3 2021 | 4 |
UROV | UROVANT SCIENCES LTD | 4 | 4 | 0.10% | 0.20% | 0.26% | Q3 2018 | Q2 2019 | 4 |
ACHN | ACHILLION PHARMACEUTIC... | 4 | 4 | 0.13% | 0.19% | 0.24% | Q1 2017 | Q4 2017 | 4 |
WD | WALKER & DUNLOP INC | 4 | 4 | 0.15% | 0.19% | 0.25% | Q1 2022 | Q4 2022 | 4 |
CHMA | CHIASMA INC | 4 | 4 | 0.11% | 0.18% | 0.25% | Q2 2020 | Q1 2021 | 4 |
DLPH | DELPHI TECHNOLOGIES PLC | 4 | 4 | 0.06% | 0.11% | 0.14% | Q4 2017 | Q3 2018 | 4 |
SNSS | SUNESIS PHARMACEUTICAL... | 4 | 4 | 0.08% | 0.10% | 0.13% | Q4 2013 | Q3 2014 | 4 |
RCUS | ARCUS BIOSCIENCES INC | 4 | 4 | 0.08% | 0.08% | 0.10% | Q4 2022 | Q3 2023 | 4 |
VFC | V F CORP | 4 | 4 | 0.03% | 0.08% | 0.10% | Q4 2020 | Q3 2021 | 4 |
EXACT SCIENCES CORP | 4 | 4 | 0.04% | 0.07% | 0.14% | Q1 2021 | Q4 2021 | 4 | |
GUARDANT HEALTH INC | 4 | 4 | 0.04% | 0.04% | 0.04% | Q4 2021 | Q3 2022 | 4 | |
DERMIRA INC | 4 | 4 | 0.02% | 0.03% | 0.04% | Q2 2018 | Q1 2019 | 4 | |
NOK | NOKIA CORP | 4 | 4 | 0.01% | 0.03% | 0.05% | Q4 2018 | Q3 2019 | 4 |
MEDICINES CO | 4 | 4 | 0.02% | 0.02% | 0.04% | Q4 2018 | Q3 2019 | 4 | |
JCI | JOHNSON CTLS INC | 4 | 4 | 0.01% | 0.02% | 0.04% | Q3 2015 | Q2 2016 | 4 |
PSA | PUBLIC STORAGE | 4 | 4 | 0.02% | 0.02% | 0.02% | Q2 2018 | Q1 2019 | 4 |
BAB | POWERSHARES ETF TR II | 4 | 4 | 0.01% | 0.01% | 0.01% | Q3 2015 | Q2 2016 | 4 |
NOW | SERVICENOW INC | 4 | 4 | 0.00% | 0.01% | 0.02% | Q4 2022 | Q3 2023 | 4 |
HERCULES CAPITAL INC | 4 | 4 | 0.01% | 0.01% | 0.01% | Q1 2018 | Q4 2018 | 4 | |
EW | EDWARDS LIFESCIENCES CORP | 4 | 4 | 0.00% | 0.01% | 0.01% | Q4 2022 | Q3 2023 | 4 |
NATI | NATIONAL INSTRS CORP | 4 | 4 | 0.00% | 0.00% | 0.01% | Q3 2015 | Q2 2016 | 4 |
IGV | ISHARES TR | 3 | 3 | 2.01% | 2.40% | 2.99% | Q1 2020 | Q3 2020 | 3 |
FEYE | FIREEYE INC | 3 | 3 | 1.94% | 2.04% | 2.19% | Q4 2014 | Q2 2015 | 3 |
TRN | TRINITY INDS INC | 3 | 3 | 1.31% | 1.77% | 2.44% | Q4 2014 | Q2 2015 | 3 |
SDRL | SEADRILL LIMITED | 3 | 3 | 1.20% | 1.42% | 1.81% | Q4 2013 | Q2 2014 | 3 |
ALTR | ALTAIR ENGR INC | 3 | 3 | 0.80% | 1.20% | 1.60% | Q3 2018 | Q1 2019 | 3 |
LAD | LITHIA MTRS INC | 3 | 3 | 0.53% | 1.03% | 1.31% | Q1 2023 | Q3 2023 | 3 |
JELD | JELD-WEN HLDG INC | 3 | 3 | 0.83% | 0.93% | 1.04% | Q4 2017 | Q2 2018 | 3 |
WSO | WATSCO INC | 3 | 3 | 0.77% | 0.83% | 0.87% | Q3 2016 | Q1 2017 | 3 |
IAA | IAA INC | 3 | 3 | 0.72% | 0.79% | 0.84% | Q2 2019 | Q4 2019 | 3 |
TLND | TALEND S A | 3 | 3 | 0.64% | 0.71% | 0.81% | Q4 2018 | Q2 2019 | 3 |
CSIQ | CANADIAN SOLAR INC | 3 | 3 | 0.56% | 0.69% | 0.87% | Q4 2015 | Q2 2016 | 3 |
KDNY | CHINOOK THERAPEUTICS INC | 3 | 3 | 0.19% | 0.68% | 1.25% | Q4 2022 | Q2 2023 | 3 |
NCNO | NCINO INC | 3 | 3 | 0.48% | 0.55% | 0.62% | Q2 2021 | Q4 2021 | 3 |
ABY | ABENGOA YIELD PLC | 3 | 3 | 0.00% | 0.51% | 0.90% | Q3 2015 | Q1 2016 | 3 |
DUOLINGO INC | 3 | 3 | 0.35% | 0.48% | 0.71% | Q4 2021 | Q2 2022 | 3 | |
ANAB | ANAPTYSBIO INC | 2 | 1 | 0.14% | 0.44% | 0.96% | Q2 2018 | Q3 2023 | 3 |
AKCA | AKCEA THERAPEUTICS INC | 3 | 3 | 0.21% | 0.42% | 0.66% | Q3 2017 | Q1 2018 | 3 |
AKRO | AKERO THERAPEUTICS INC | 3 | 3 | 0.27% | 0.34% | 0.47% | Q1 2023 | Q3 2023 | 3 |
MDCO | MEDICINES CO | 3 | 3 | 0.28% | 0.33% | 0.37% | Q4 2018 | Q2 2019 | 3 |
SHC | SOTERA HEALTH CO | 3 | 3 | 0.28% | 0.32% | 0.37% | Q4 2020 | Q2 2021 | 3 |
MDGL | MADRIGAL PHARMACEUTICA... | 3 | 3 | 0.14% | 0.31% | 0.53% | Q1 2018 | Q3 2018 | 3 |
BYND | BEYOND MEAT INC | 3 | 3 | 0.21% | 0.28% | 0.32% | Q1 2021 | Q3 2021 | 3 |
BFLY | BUTTERFLY NETWORK INC | 3 | 3 | 0.24% | 0.26% | 0.28% | Q1 2021 | Q3 2021 | 3 |
MNDY | MONDAY COM LTD | 2 | 1 | 0.04% | 0.24% | 0.58% | Q1 2022 | Q3 2023 | 3 |
BAX | BAXTER INTL INC | 3 | 3 | 0.20% | 0.23% | 0.27% | Q2 2022 | Q4 2022 | 3 |
SBTX | SILVERBACK THERAPEUTIC... | 3 | 3 | 0.15% | 0.21% | 0.24% | Q4 2020 | Q2 2021 | 3 |
ADVM | ADVERUM BIOTECHNOLOGIE... | 3 | 3 | 0.16% | 0.21% | 0.26% | Q4 2018 | Q2 2019 | 3 |
CERE | CEREVEL THERAPEUTICS H... | 3 | 3 | 0.14% | 0.20% | 0.26% | Q1 2023 | Q3 2023 | 3 |
R1 RCM INC | 3 | 3 | 0.16% | 0.20% | 0.23% | Q1 2023 | Q3 2023 | 3 | |
APTVPRA | APTIV PLC | 2 | 1 | 0.15% | 0.19% | 0.21% | Q4 2021 | Q3 2022 | 3 |
AMBI | AMBIT BIOSCIENCES CORP | 3 | 3 | 0.14% | 0.18% | 0.22% | Q4 2013 | Q2 2014 | 3 |
APTVPRA | APTIV PLC | 2 | 1 | 0.17% | 0.18% | 0.20% | Q1 2022 | Q1 2023 | 3 |
DNLI | DENALI THERAPEUTICS INC | 3 | 3 | 0.13% | 0.17% | 0.23% | Q1 2023 | Q3 2023 | 3 |
APTOSE BIOSCIENCES INC | 3 | 3 | 0.10% | 0.15% | 0.20% | Q4 2020 | Q2 2021 | 3 | |
EQT | EQT CORP | 2 | 1 | 0.07% | 0.14% | 0.23% | Q3 2022 | Q3 2023 | 3 |
AAVL | AVALANCHE BIOTECHNOLOG... | 3 | 3 | 0.10% | 0.13% | 0.19% | Q3 2014 | Q1 2015 | 3 |
ITT | ITT INC | 3 | 3 | 0.08% | 0.11% | 0.14% | Q2 2020 | Q4 2020 | 3 |
VICL | VICAL INC | 3 | 3 | 0.01% | 0.10% | 0.16% | Q4 2017 | Q2 2018 | 3 |
AQNU | ALGONQUIN PWR UTILS CORP | 3 | 3 | 0.08% | 0.09% | 0.09% | Q2 2021 | Q4 2021 | 3 |
TER | TERADYNE INC | 3 | 3 | 0.02% | 0.05% | 0.08% | Q4 2019 | Q2 2020 | 3 |
HCP | HCP INC | 2 | 1 | 0.00% | 0.05% | 0.09% | Q3 2015 | Q3 2019 | 3 |
EIGR | EIGER BIOPHARMACEUTICA... | 3 | 3 | 0.02% | 0.05% | 0.09% | Q4 2017 | Q2 2018 | 3 |
AMD | ADVANCED MICRO DEVICES... | 3 | 3 | 0.01% | 0.02% | 0.04% | Q3 2020 | Q1 2021 | 3 |
SAREPTA THERAPEUTICS INC | 3 | 3 | 0.02% | 0.02% | 0.03% | Q4 2019 | Q2 2020 | 3 | |
BIP | BROOKFIELD INFRAST PAR... | 2 | 1 | 0.00% | 0.01% | 0.02% | Q4 2015 | Q4 2016 | 3 |
SYK | STRYKER CORP | 3 | 3 | 0.00% | 0.01% | 0.01% | Q3 2015 | Q1 2016 | 3 |
DLR | DIGITAL RLTY TR INC | 3 | 3 | 0.00% | 0.00% | 0.00% | Q3 2015 | Q1 2016 | 3 |
SE | SPECTRA ENERGY CORP | 3 | 3 | 0.00% | 0.00% | 0.01% | Q3 2015 | Q1 2016 | 3 |
RMR | RMR GROUP INC | 3 | 3 | 0.00% | 0.00% | 0.00% | Q4 2015 | Q2 2016 | 3 |
SEND | SENDGRID INC | 2 | 2 | 2.66% | 3.04% | 3.43% | Q3 2018 | Q4 2018 | 2 |
ROC | ROCKWOOD HLDGS INC | 2 | 2 | 1.76% | 1.86% | 1.97% | Q1 2014 | Q2 2014 | 2 |
SERV | SERVICEMASTER GLOBAL H... | 2 | 2 | 1.10% | 1.24% | 1.38% | Q2 2019 | Q3 2019 | 2 |
FSLR | FIRST SOLAR INC | 2 | 2 | 0.38% | 1.03% | 1.68% | Q1 2016 | Q2 2016 | 2 |
SJM | SMUCKER J M CO | 2 | 2 | 0.70% | 0.93% | 1.15% | Q4 2013 | Q1 2014 | 2 |
3106PS | DELPHI AUTOMOTIVE PLC | 2 | 2 | 0.86% | 0.87% | 0.88% | Q2 2017 | Q3 2017 | 2 |
NOV | NATIONAL OILWELL VARCO... | 2 | 2 | 0.57% | 0.87% | 1.16% | Q4 2013 | Q1 2014 | 2 |
ECL | ECOLAB INC | 2 | 2 | 0.76% | 0.83% | 0.90% | Q3 2020 | Q4 2020 | 2 |
TOAST INC | 2 | 2 | 0.61% | 0.80% | 0.98% | Q2 2023 | Q3 2023 | 2 | |
AKBA | AKEBIA THERAPEUTICS INC | 2 | 2 | 0.51% | 0.57% | 0.63% | Q2 2014 | Q3 2014 | 2 |
ESTC | ELASTIC N V | 2 | 2 | 0.41% | 0.49% | 0.58% | Q3 2019 | Q4 2019 | 2 |
FANG | DIAMONDBACK ENERGY INC | 2 | 2 | 0.25% | 0.36% | 0.47% | Q2 2023 | Q3 2023 | 2 |
BLU | BELLUS HEALTH INC NEW | 1 | 1 | 0.29% | 0.32% | 0.34% | Q2 2020 | Q1 2023 | 2 |
COG | CABOT OIL & GAS CORP | 2 | 2 | 0.18% | 0.30% | 0.42% | Q4 2013 | Q1 2014 | 2 |
RTRX | RETROPHIN INC | 2 | 2 | 0.28% | 0.29% | 0.30% | Q2 2015 | Q3 2015 | 2 |
SHPG | SHIRE PLC | 2 | 2 | 0.23% | 0.25% | 0.28% | Q4 2013 | Q1 2014 | 2 |
RPHM | RENEO PHARMACEUTICALS INC | 2 | 2 | 0.19% | 0.24% | 0.28% | Q2 2023 | Q3 2023 | 2 |
ARQL | ARQULE INC | 2 | 2 | 0.13% | 0.24% | 0.35% | Q4 2018 | Q1 2019 | 2 |
RXDX | IGNYTA INC | 2 | 2 | 0.22% | 0.23% | 0.24% | Q2 2017 | Q3 2017 | 2 |
HSACU | HEALTH SCIENCES ACQUST... | 2 | 2 | 0.22% | 0.23% | 0.24% | Q2 2019 | Q3 2019 | 2 |
ESPR | ESPERION THERAPEUTICS ... | 2 | 2 | 0.17% | 0.22% | 0.27% | Q1 2015 | Q2 2015 | 2 |
ALDR | ALDER BIOPHARMACEUTICA... | 2 | 2 | 0.11% | 0.20% | 0.29% | Q4 2016 | Q1 2017 | 2 |
ARWR | ARROWHEAD RESH CORP | 2 | 2 | 0.16% | 0.20% | 0.24% | Q2 2014 | Q3 2014 | 2 |
RVMD | REVOLUTION MEDICINES INC | 2 | 2 | 0.16% | 0.17% | 0.18% | Q2 2023 | Q3 2023 | 2 |
FMI | FOUNDATION MEDICINE INC | 2 | 2 | 0.08% | 0.17% | 0.25% | Q4 2013 | Q1 2014 | 2 |
BLCM | BELLICUM PHARMACEUTICA... | 2 | 2 | 0.11% | 0.16% | 0.22% | Q4 2016 | Q1 2017 | 2 |
IMTX | IMMATICS N.V | 2 | 2 | 0.13% | 0.15% | 0.17% | Q3 2020 | Q4 2020 | 2 |
ATHX | ATHERSYS INC | 2 | 2 | 0.13% | 0.14% | 0.14% | Q4 2013 | Q1 2014 | 2 |
OPCH | OPTION CARE HEALTH INC | 2 | 2 | 0.13% | 0.13% | 0.14% | Q2 2022 | Q3 2022 | 2 |
CERS | CERUS CORP | 2 | 2 | 0.07% | 0.13% | 0.19% | Q4 2013 | Q1 2014 | 2 |
IOVA | IOVANCE BIOTHERAPEUTIC... | 2 | 2 | 0.12% | 0.13% | 0.15% | Q2 2018 | Q3 2018 | 2 |
MDAS | MEDASSETS INC | 2 | 2 | 0.10% | 0.13% | 0.16% | Q4 2013 | Q1 2014 | 2 |
RMD | RESMED INC | 2 | 2 | 0.07% | 0.11% | 0.14% | Q4 2013 | Q1 2014 | 2 |
TIG | TIGENIX | 2 | 2 | 0.10% | 0.10% | 0.10% | Q4 2016 | Q1 2017 | 2 |
AEGR | AEGERION PHARMACEUTICA... | 2 | 2 | 0.09% | 0.09% | 0.09% | Q2 2014 | Q3 2014 | 2 |
AQN | ALGONQUIN PWR UTILS CORP | 2 | 2 | 0.04% | 0.08% | 0.12% | Q1 2020 | Q2 2020 | 2 |
OKE | ONEOK INC NEW | 2 | 2 | 0.08% | 0.08% | 0.09% | Q3 2019 | Q4 2019 | 2 |
CMPX | COMPASS THERAPEUTICS INC | 2 | 2 | 0.05% | 0.07% | 0.09% | Q3 2022 | Q4 2022 | 2 |
HTWR | HEARTWARE INTL INC | 2 | 2 | 0.04% | 0.07% | 0.09% | Q4 2013 | Q1 2014 | 2 |
BRKS | AZENTA INC | 2 | 2 | 0.04% | 0.06% | 0.08% | Q4 2021 | Q1 2022 | 2 |
CMTA | CLEMENTIA PHARMACEUTIC... | 2 | 2 | 0.06% | 0.06% | 0.06% | Q3 2017 | Q4 2017 | 2 |
RINGCENTRAL INC | 2 | 2 | 0.05% | 0.06% | 0.06% | Q1 2021 | Q2 2021 | 2 | |
AMWL | AMERICAN WELL CORP | 2 | 2 | 0.04% | 0.05% | 0.06% | Q3 2020 | Q4 2020 | 2 |
RXO INC | 2 | 2 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q1 2023 | 2 | |
DPZ | DOMINOS PIZZA INC | 2 | 2 | 0.02% | 0.03% | 0.04% | Q3 2020 | Q4 2020 | 2 |
XOMETRY INC | 2 | 2 | 0.03% | 0.03% | 0.03% | Q2 2023 | Q3 2023 | 2 | |
IMTXW | IMMATICS N.V | 2 | 2 | 0.02% | 0.02% | 0.03% | Q3 2020 | Q4 2020 | 2 |
EQR | EQUITY RESIDENTIAL | 2 | 2 | 0.01% | 0.02% | 0.03% | Q2 2019 | Q3 2019 | 2 |
CCIPRA | CROWN CASTLE INTL CORP... | 2 | 2 | 0.01% | 0.01% | 0.01% | Q3 2019 | Q4 2019 | 2 |
ALGN | ALIGN TECHNOLOGY INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q2 2023 | Q3 2023 | 2 |
TESLA MTRS INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q1 2016 | Q2 2016 | 2 | |
GOV | GOVERNMENT PPTYS INCOM... | 2 | 2 | 0.00% | 0.01% | 0.01% | Q4 2015 | Q1 2016 | 2 |
CDXS | CODEXIS INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q1 2015 | Q2 2015 | 2 |
ZFGN | ZAFGEN INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2014 | Q1 2015 | 2 |
ASPEN TECHNOLOGY INC | 1 | 1 | 1.66% | 1.66% | 1.66% | Q4 2013 | Q4 2013 | 1 | |
SNDK | SANDISK CORP | 1 | 1 | 1.54% | 1.54% | 1.54% | Q1 2015 | Q1 2015 | 1 |
BIOHAVEN LTD | 1 | 1 | 1.47% | 1.47% | 1.47% | Q3 2022 | Q3 2022 | 1 | |
W | WAYFAIR INC | 1 | 1 | 0.97% | 0.97% | 0.97% | Q1 2020 | Q1 2020 | 1 |
SAGE | SAGE THERAPEUTICS INC | 1 | 1 | 0.86% | 0.86% | 0.86% | Q4 2017 | Q4 2017 | 1 |
DWSN | DAWSON GEOPHYSICAL CO | 1 | 1 | 0.68% | 0.68% | 0.68% | Q4 2013 | Q4 2013 | 1 |
PS | PLURALSIGHT INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q2 2019 | Q2 2019 | 1 |
EDIT | EDITAS MEDICINE INC | 1 | 1 | 0.58% | 0.58% | 0.58% | Q4 2020 | Q4 2020 | 1 |
IMVTU | IMMUNOVANT INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q4 2019 | Q4 2019 | 1 |
NTLA | INTELLIA THERAPEUTICS INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q4 2020 | Q4 2020 | 1 |
AXSM | AXSOME THERAPEUTICS INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q3 2023 | Q3 2023 | 1 |
WTRH | WAITR HLDGS INC | 1 | 1 | 0.43% | 0.43% | 0.43% | Q4 2018 | Q4 2018 | 1 |
FERG | FERGUSON PLC NEW | 1 | 1 | 0.43% | 0.43% | 0.43% | Q3 2023 | Q3 2023 | 1 |
PCVX | VAXCYTE INC | 1 | 1 | 0.36% | 0.36% | 0.36% | Q3 2023 | Q3 2023 | 1 |
LGVW | LONGVIEW ACQUISITION CORP | 1 | 1 | 0.34% | 0.34% | 0.34% | Q4 2020 | Q4 2020 | 1 |
HASHICORP INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q2 2023 | Q2 2023 | 1 | |
FGEN | FIBROGEN INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q1 2023 | Q1 2023 | 1 |
JAMF | JAMF HLDG CORP | 1 | 1 | 0.32% | 0.32% | 0.32% | Q3 2020 | Q3 2020 | 1 |
CLVS | CLOVIS ONCOLOGY INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q1 2014 | Q1 2014 | 1 |
ALKS | ALKERMES PLC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q2 2023 | Q2 2023 | 1 |
HLI | HOULIHAN LOKEY INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q3 2023 | Q3 2023 | 1 |
ARYA | ARYA SCIENCES ACQUISIT... | 1 | 1 | 0.27% | 0.27% | 0.27% | Q2 2020 | Q2 2020 | 1 |
NCINO INC | 1 | 1 | 0.27% | 0.27% | 0.27% | Q1 2022 | Q1 2022 | 1 | |
FIVN | FIVE9 INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2021 | Q3 2021 | 1 |
AESC | AES CORP | 1 | 1 | 0.26% | 0.26% | 0.26% | Q1 2023 | Q1 2023 | 1 |
VRNA | VERONA PHARMA PLC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q3 2023 | Q3 2023 | 1 |
ZIP | ZIPRECRUITER INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q1 2023 | Q1 2023 | 1 |
INZY | INOZYME PHARMA INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q3 2023 | Q3 2023 | 1 |
RLAY | RELAY THERAPEUTICS INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q3 2020 | Q3 2020 | 1 |
ARDX | ARDELYX INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q3 2023 | Q3 2023 | 1 |
HRTX | HERON THERAPEUTICS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q4 2016 | Q4 2016 | 1 |
VSAR | VERSARTIS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q2 2014 | Q2 2014 | 1 |
WPX | WPX ENERGY INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q4 2014 | Q4 2014 | 1 |
ABCL | ABCELLERA BIOLOGICS INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q4 2020 | Q4 2020 | 1 |
FREQ | FREQUENCY THERAPEUTICS... | 1 | 1 | 0.18% | 0.18% | 0.18% | Q3 2023 | Q3 2023 | 1 |
IDYA | IDEAYA BIOSCIENCES INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q3 2023 | Q3 2023 | 1 |
SGFY | SIGNIFY HEALTH INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2021 | Q1 2021 | 1 |
INBX | INHIBRX INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2023 | Q3 2023 | 1 |
DVN | DEVON ENERGY CORP NEW | 1 | 1 | 0.13% | 0.13% | 0.13% | Q4 2022 | Q4 2022 | 1 |
CERC | CERECOR INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2019 | Q1 2019 | 1 |
BCAB | BIOATLA INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2022 | Q3 2022 | 1 |
KNTE | KINNATE BIOPHARMA INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q4 2020 | Q4 2020 | 1 |
SVRA | SAVARA INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2019 | Q2 2019 | 1 |
ACCURAY INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2016 | Q1 2016 | 1 | |
MAAC | MONTES ARCHIMEDES ACQU... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2021 | Q2 2021 | 1 |
GPI | GROUP 1 AUTOMOTIVE INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2023 | Q3 2023 | 1 |
ONTX | ONCONOVA THERAPEUTICS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2013 | Q4 2013 | 1 |
VVUS | VIVUS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2013 | Q4 2013 | 1 |
NEXTERA ENERGY INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2022 | Q4 2022 | 1 | |
ENPHASE ENERGY INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2022 | Q1 2022 | 1 | |
BXP | BOSTON PROPERTIES INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2019 | Q4 2019 | 1 |
VST | VISTRA CORP | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2023 | Q3 2023 | 1 |
TNDM | TANDEM DIABETES CARE INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2018 | Q1 2018 | 1 |
NEXTERA ENERGY INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2023 | Q1 2023 | 1 | |
TCF | TCF FINANCIAL CORPORAT... | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2020 | Q2 2020 | 1 |
OLK | OLINK HLDG AB | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2021 | Q1 2021 | 1 |
INTA | INTAPP INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2023 | Q3 2023 | 1 |
IMVTW | IMMUNOVANT INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2020 | Q1 2020 | 1 |
TURNSTONE BIOLOGICS CORP | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2023 | Q3 2023 | 1 | |
ARYAW | ARYA SCIENCES ACQUISIT... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2020 | Q2 2020 | 1 |
MNLO | MENLO THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2018 | Q1 2018 | 1 |
DBTX | DECIBEL THERAPEUTICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2021 | Q1 2021 | 1 |
PXD | PIONEER NAT RES CO | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2023 | Q3 2023 | 1 |
RPM | RPM INTL INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2021 | Q3 2021 | 1 |
FATE | FATE THERAPEUTICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2020 | Q4 2020 | 1 |
INTERCEPT PHARMACEUTIC... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2019 | Q4 2019 | 1 | |
PATH | UIPATH INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2021 | Q3 2021 | 1 |
FNB | FNB CORP PA | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2019 | Q4 2019 | 1 |
NERDWALLET INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2023 | Q2 2023 | 1 | |
INTERCEPT PHARMACEUTIC... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2019 | Q4 2019 | 1 | |
INFO | IHS MARKIT LTD | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2019 | Q4 2019 | 1 |
ESS | ESSEX PPTY TR INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2019 | Q3 2019 | 1 |
TTD | THE TRADE DESK INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2021 | Q1 2021 | 1 |
SIVB | SVB FINL GROUP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2019 | Q4 2019 | 1 |
ALV | AUTOLIV INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2023 | Q3 2023 | 1 |
AYX | ALTERYX INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2021 | Q2 2021 | 1 |
SPGI | S&P GLOBAL INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2023 | Q3 2023 | 1 |
LMND | LEMONADE INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
SHOP | SHOPIFY INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2023 | Q3 2023 | 1 |
LINDE PLC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2023 | Q3 2023 | 1 | |
PLANET LABS PBC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2021 | Q4 2021 | 1 | |
BRBR | BELLRING BRANDS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2020 | Q2 2020 | 1 |
NEWR | NEW RELIC INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
ONTF | ON24 INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2021 | Q1 2021 | 1 |
GNMA | ISHARES TR | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2015 | Q3 2015 | 1 |
AMWL | AMERICAN WELL CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
CCOI | COGENT COMMUNICATIONS ... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2020 | Q1 2020 | 1 |
HERCULES CAPITAL INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2019 | Q1 2019 | 1 | |
LMND | LEMONADE INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2021 | Q2 2021 | 1 |
APPN | APPIAN CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
OSH | OAK STR HEALTH INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2020 | Q3 2020 | 1 |
WDC | WESTERN DIGITAL CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2019 | Q1 2019 | 1 |
ITC | ITC HLDGS CORP | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2015 | Q4 2015 | 1 |
PATTERN ENERGY GROUP INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2019 | Q1 2019 | 1 | |
AGM | FEDERAL AGRIC MTG CORP | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2015 | Q3 2015 | 1 |
DLO | DLOCAL LTD | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2023 | Q1 2023 | 1 |
HCN | HEALTH CARE REIT INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2015 | Q3 2015 | 1 |
Download |
The securities at the top of the list , including LOWES COS INC, PALO ALTO NETWORKS INC, and ASML HOLDINGS NV, are the highest-conviction holdings of Eventide Asset Management.
The conviction is calculated by counting the number of quarters a security has been reported by Eventide Asset Management. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Eventide Asset Management owns currently or has owned in the past.